BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 9, 2026
Home
»
Topics
» Cancer, BioWorld Science
Cancer, BioWorld Science
RSS
CureVac enters licensing agreement with LICR for three tumor-associated antigens
June 3, 2008
Human Genome Sciences has initiated dosing in phase I HGS-1029
June 2, 2008
Phase I data show activity of NKTR-102 in solid tumor patients
June 2, 2008
SymBio completes enrollment in phase II study in indolent non-Hodgkin's lymphoma
June 2, 2008
Triphendiol safe in phase Ia pharmacokinetic study
June 2, 2008
Novartis pays USD 25 million milestone payment to Antisoma in relation to ASA-404
June 2, 2008
Genmab initiates phase I/II zalutumumab combination study in colorectal cancer
May 30, 2008
Cell-based osteoprotegerin therapy prevents bone metastasis in prostate cancer model
May 30, 2008
Alfacell presents phase IIIb results for Onconase trial in malignant mesothelioma
May 30, 2008
Advexin improves survival in recurrent, refractory head and neck cancer
May 30, 2008
Previous
1
2
…
2420
2421
2422
2423
2424
2425
2426
2427
2428
…
3677
3678
Next